Hikal Limited
Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are…
What Hikal files
- Others53
- Important34
- Investor Meet28
- Updates16
- Board Meeting12
- Dividend/Bonus8
Hikal Ltd. will host an in-person Group Meeting for Analysts and Institutional Investors at its Pune R&T centre on September 04, 2026, from 12:00 P.M. onwards. Participants will interact with company officials, with discussions based on publicly available information.
Hikal Limited has informed the Exchange about Copy of Newspaper Publication
Hikal has announced its 38th Annual General Meeting. The Annual Report for FY26 is available on the company website. Shareholders must update KYC details and dematerialize physical shares to ensure receipt of future payments like dividends.
Hikal's full-year results show a loss of 48.7 Cr on revenue of 1,712.6 Cr due to headwinds and exceptional charges. Operational recovery is underway, boosting optimism. The company commissioned new HPAPI and Kilo labs, launched a Personal Care facility, and proposed Sameer Hiremath as Chairman & MD.
Hikal Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026